Citations

Citations to this article as recorded by  

• The impact of hepatic steatosis on epicardial adipose tissue in obese individuals
  Gül Trabzon, Fatma Öztürk Keleş, Osman Fırat Çalışkan, Şükrü Güngör, Nuriye Yarar, Ufuk Utku Güllü
  Journal of Pediatric Endocrinology and Metabolism.2026; 39(1): 46.     CrossRef
• Pharmabiotics, Phocaeicola dorei, ameliorates cholestatic liver fibrosis by alleviating macrophage efferocytosis of neutrophils
  Jung A Eom, In Gyu Park, Ji Ye Hyun, Na Young Lee, Goo Hyun Kwon, Sang Jun Yoon, Sung-Min Won, Young Lim Ham, Kyeong Jin Lee, Sang Hak Han, Dong-Hoon Yang, Dong Joon Kim, Ki Tae Suk
  Nature Communications.2026;[Epub]     CrossRef
• Phocaeicola coprocola attenuates liver fibrosis by modulating extracellular matrix remodeling
  Kyeong Jin Lee, Jeong Ha Park, Hyunjoon Park, Min Ju Kim, Hoyeong Yoon, Jeong Min Kim, Sang Hak Han, Ki Tae Suk
  Gut Microbes.2026;[Epub]     CrossRef
• Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases
  Yiyuan Xiao, Sihua Xu, Wenyan Hu, Jiapeng Huang, Deke Jiang, Rong Na, Zhaoqing Yin, Jingjing Zhang, Haitao Chen
  Annals of Hepatology.2025; 30(1): 101750.     CrossRef
• Bioinformatic analysis of molecular expression patterns during the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD)
  Yuanfeng Lan, Ran Song, Duiping Feng, Junqi He
  Scientific Reports.2025;[Epub]     CrossRef
• Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
  Toru Nakamura, Atsutaka Masuda, Dan Nakano, Keisuke Amano, Tomoya Sano, Masahito Nakano, Takumi Kawaguchi
  Cells.2025; 14(6): 428.     CrossRef
• C-C motif chemokines ligand 7 contributes to metabolic dysfunction-associated steatotic liver disease by enabling redox-sensitive induction of hypermethylated in cancer 1
  Xinyue Sun, Jinge Wu, Huiqian Lv, Ben Wang, Xuelian Chen, Wenjing Ren, Xiulian Miao, Yan Guo, Xiaocen Kong, Huihui Xu, Zeqing Bao, Yong Xu, Zilong Li
  Metabolism.2025; 168: 156242.     CrossRef
• Phocaeicola dorei ameliorates progression of steatotic liver disease by regulating bile acid, lipid, inflammation and proliferation
  Jieun Choi, Ye Rin Choi, Min Kyo Jeong, Hyun Ho Song, Jeong Seok Yu, Seol Hui Song, Jeong Ha Park, Min Ju Kim, Hyunjoon Park, Young Lim Ham, Sang Hak Han, Dong Joon Kim, Do Yup Lee, Ki Tae Suk
  Gut Microbes.2025;[Epub]     CrossRef
• The effects of next generation probiotics on metabolic dysfunction-associated steatotic liver disease: a parallel, double-blind, randomized, placebo-controlled trial
  Sung-Min Won, Hyunchae Joung, In Gyu Park, Sang Hak Han, Young Lim Ham, Ji Sook Han, Yoojin Kwon, Dong Joon Kim, Ki Tae Suk
  Journal of Translational Medicine.2025;[Epub]     CrossRef
• Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation
  Byeong Hyun Min, Shivani Devi, Goo Hyun Kwon, Haripriya Gupta, Jin-Ju Jeong, Satya Priya Sharma, Sung-Min Won, Ki-Kwang Oh, Sang Jun Yoon, Hee Jin Park, Jung A Eom, Min Kyo Jeong, Ji Ye Hyun, Nattan Stalin, Tae-Sik Park, Jieun Choi, Do Yup Lee, Sang Hak H
  Gut Microbes.2024;[Epub]     CrossRef
• Association of metabolic dysfunction‐associated steatotic liver disease with erosive esophagitis development: a longitudinal observational study
  Masahiro Sogabe, Toshiya Okahisa, Miwako Kagawa, Motoko Sei, Hiroyuki Ueda, Reiko Yokoyama, Kaizo Kagemoto, Hironori Tanaka, Yoshifumi Kida, Fumika Nakamura, Tetsu Tomonari, Koichi Okamoto, Yutaka Kawano, Hiroshi Miyamoto, Yasushi Sato, Masahiko Nakasono,
  Journal of Gastroenterology and Hepatology.2024; 39(6): 1107.     CrossRef
• Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019
  Pojsakorn Danpanichkul, Kanokphong Suparan, Priyata Dutta, Chuthathip Kaeosri, Banthoon Sukphutanan, Yanfang Pang, Narathorn Kulthamrongsri, Methasit Jaisa-aad, Cheng Han Ng, Margaret Teng, Masahito Nakano, Asahiro Morishita, Naim Alkhouri, Ju Dong Yang,
  Metabolism.2024; 158: 155958.     CrossRef
• Gut microbiota-based machine-learning signature for the diagnosis of alcohol-associated and metabolic dysfunction-associated steatotic liver disease
  In-gyu Park, Sang Jun Yoon, Sung-min Won, Ki-Kwang Oh, Ji Ye Hyun, Ki Tae Suk, Unjoo Lee
  Scientific Reports.2024;[Epub]     CrossRef
• Are transmembrane 6 superfamily member 2 gene polymorphisms associated with steatohepatitis after pancreaticoduodenectomy?
  Tomotaka Mori, Eisuke Ozawa, Ryu Sasaki, Akane Shimakura, Kosuke Takahashi, Yoko Kido, Yasuko Kanda, Satoshi Matsuo, Kazuaki Tajima, Asami Beppu, Yasuhiko Nakao, Masanori Fukushima, Masafumi Haraguchi, Satoshi Miuma, Hisamitsu Miyaaki, Tomohiko Adachi, Su
  JGH Open.2024;[Epub]     CrossRef
• Association between nonalcholic fatty liver disease and pancreatic cancer: Epidemiology, mechanisms, and antidiabetic medication
  Takahiko Sakaue, Hiroya Terabe, Hidetoshi Takedatsu, Takumi Kawaguchi
  Hepatology Research.2024; 54(8): 729.     CrossRef
• Usefulness of health checkup‐based indices in identifying metabolic dysfunction‐associated steatotic liver disease
  Takao Miwa, Satoko Tajirika, Nanako Imamura, Miho Adachi, Ryo Horita, Tatsunori Hanai, Cheng Han Ng, Mohammad Shadab Siddiqui, Taku Fukao, Masahito Shimizu, Mayumi Yamamoto
  JGH Open.2024;[Epub]     CrossRef